Characteristics and results of eligible prognostic studies evaluating surviving.

N., number; ADC, adenocarcinoma; SCC, squamous cell carcinoma; NSCLC, non-small cell lung cancer; IHC, immunohistochemistry; TMA, tissue microarray; FISH, fluorescence in situ hybridization; RT-PCR, reverse transcription-polymerase chain reaction; NA, not applicable; HR, hazard ratio; Sur. Curve, survival curve.N.：编号（number）；ADC：腺癌（adenocarcinoma）；SCC：鳞状细胞癌（squamous cell carcinoma）；NSCLC：非小细胞肺癌（non-small cell lung cancer）；IHC：免疫组织化学（immunohistochemistry）；TMA：组织微阵列（tissue microarray）；FISH：荧光原位杂交（fluorescence in situ hybridization）；RT-PCR：逆转录聚合酶链反应（reverse transcription-polymerase chain reaction）；NA：不适用（not applicable）；HR：风险比（hazard ratio）；Sur. Curve：生存曲线（survival curve）